Suchergebnisse - "Tammemagi, Martin"

PubPharm (8)

1

Machine Learning for Early Lung Cancer Identification Using Routine Clinical and Laboratory Data

enthalten in: American journal of respiratory and critical care medicine | 2021

von Gould, M. | Huang, B. | Tammemagi, M. | +2

CommentIn: Am J Respir Crit Care Med. 2021 Aug 15;204(4):389-390. - PMID 34097833

2

Recommendations for Implementing Lung Cancer Screening with Low-Dose Computed Tomography in Europe

enthalten in: Cancers | 2020

von Veronesi, G. | Baldwin, D. | Henschke, C. | +34

3

Protocol and Rationale for the International Lung Screening Trial

enthalten in: Annals of the American Thoracic Society | 2020

von Lim, K. | Marshall, H. | Tammemägi, M. | +64

4

Trial marketing in the Pan-Canadian Early Detection of Lung Cancer Study

enthalten in: Clinical trials (London, England) | 2020

von Rudkowski, J. | Pond, G. | Tremblay, A. | +12

5

Prediction of lung cancer risk at follow-up screening with low-dose CT : a training and validation study of a deep learning method

enthalten in: The Lancet. Digital health | 2019

von Huang, P. | Lin, C. | Li, Y. | +17

CommentIn: Lancet Digit Health. 2019 Nov;1(7):e324-e325. - PMID 33323204

6

Application of Lung-Screening Reporting and Data System Versus Pan-Canadian Early Detection of Lung Cancer Nodule Risk Calculation in the Alberta Lung Cancer Screening Study

enthalten in: Journal of the American College of Radiology : JACR | 2019

von Tremblay, A. | Taghizadeh, N. | MacGregor, J. | +16

7

Health-related quality of life and anxiety in the PAN-CAN lung cancer screening cohort

enthalten in: BMJ open | 2019

von Taghizadeh, N. | Tremblay, A. | Cressman, S. | +17

8

Low Prevalence of High-Grade Lesions Detected With Autofluorescence Bronchoscopy in the Setting of Lung Cancer Screening in the Pan-Canadian Lung Cancer Screening Study

enthalten in: Chest | 2016

von Tremblay, A. | Taghizadeh, N. | McWilliams, A. | +25

CommentIn: Chest. 2016 Nov;150(5):993-994. - PMID 27832892

1
[1]